Charles River Laboratories International (CRL) Income from Continuing Operations (2009 - 2025)

Charles River Laboratories International (CRL) has reported Income from Continuing Operations for 17 consecutive years, with 276290000.0 the latest figure, recorded in Q4 2025.

• In Q4 2025, Income from Continuing Operations fell 29.26% year-over-year to 276290000.0; the TTM figure through Dec 2025 stood at 142163000.0 (down 662.11% YoY), while the FY2025 annual figure was 142163000.0, down 662.11% from the prior year.
• Income from Continuing Operations came in at 276290000.0 for Q4 2025 at Charles River Laboratories International, down from 55556000.0 in the prior quarter.
• The five-year high for Income from Continuing Operations was 189106000.0 in Q4 2022, with the low at 276290000.0 in Q4 2025.
• Average Income from Continuing Operations over 5 years is 62747150.0, with a median of 92088500.0 recorded in 2021.
• Across the five-year window, Income from Continuing Operations surged 48.94% in 2022 and sank 213.12% in 2024, its largest moves.
• Year by year, Income from Continuing Operations stood at 139827000.0 in 2021, then surged by 35.24% to 189106000.0 in 2022, then declined by 0.08% to 188952000.0 in 2023, then tumbled by 213.12% to 213747000.0 in 2024, then declined by 29.26% to 276290000.0 in 2025.
• According to Business Quant data, Income from Continuing Operations over the past three periods registered 276290000.0, 55556000.0, and 52693000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.